Ignite Creation Date:
2025-12-25 @ 4:22 AM
Ignite Modification Date:
2026-05-20 @ 2:50 AM
Study NCT ID:
NCT06275620
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-10-30
First Post:
2024-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
Sponsor:
Beacon Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AGTC-RPGR-001 DAWN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None